Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.36 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 5/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL225077 | 0.78 | GAA (0.41) | MEN1KMT2AL3MBTL1SMN1; SMN2ATM | |
| SCHEMBL3109009 | 0.76 | TACR1 (0.39) | SLC6A2SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL7086681 | 0.76 | NPC1 (0.42) | MEN1KMT2ASMN1; SMN2ATMTDP1 | |
| SCHEMBL6374832 | 0.76 | SMN1; SMN2 (0.38) | MEN1KMT2AL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL28401917 | 0.75 | LMNA (0.38) | BRD4SLC6A2SLC6A4SLC6A3MEN1 | |
| SCHEMBL8171301 | 0.75 | LMNA (0.35) | MEN1KMT2AHPGD | |
| SCHEMBL6204059 | 0.74 | BRD4 (0.50) | BRD4SLC6A2SLC6A4SLC6A3MEN1 | |
| SCHEMBL22612081 | 0.74 | LMNA (0.34) | MEN1KMT2AHPGD | |
| Lithium SCHEMBL29406710 | 0.74 | LMNA (0.34) | MEN1KMT2AHPGD | |
| SCHEMBL7183325 | 0.71 | CYP2C9 (0.38) | MEN1KMT2AALDH1A1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110382561-B | Sealing composition | 味之素株式会社 | 2023-01-31 | — | — | CN | disclosed |
| US-11370942-B2 | Pressure-sensitive adhesive composition | LG CHEM, LTD. (KR) | 2022-06-28 | — | — | US | disclosed |
| CN-111757910-B | Sealing resin composition | 味之素株式会社 | 2022-06-24 | — | — | CN | disclosed |
| CN-111757910-A | Sealing resin composition | 味之素株式会社 | 2020-10-09 | — | — | CN | disclosed |
| US-10761443-B2 | Charge transport molecule having hydrogen for an overcoat of a photoconductor | LEXMARK INTERNATIONAL, INC. (US) | 2020-09-01 | — | — | US | disclosed |
| US-10732528-B2 | Overcoat for a photoconductor with tetrafunctional radical polymerizable charge transport molecule having hydrogen | LEXMARK INTERNATIONAL, INC. (US) | 2020-08-04 | — | — | US | disclosed |
| US-10684565-B2 | Photoconductor overcoat having a charge transport molecule with four radical polymerizable hydrophilic functional groups containing an oxygen atom and method of making the same | LEXMARK INTERNATIONAL, INC. (US) | 2020-06-16 | — | — | US | disclosed |
| US-10481512-B2 | Photoconductor having protective overcoat layer with a charge transport molecule with four radical polymerizable hydrophilic functional groups containing an oxygen atom and method of making the same | LEXMARK INTERNATIONAL, INC. (US) | 2019-11-19 | — | — | US | disclosed |
| US-10435596-B2 | Pressure-sensitive adhesive composition | LG CHEM, LTD. (KR) | 2019-10-08 | — | — | US | disclosed |
| US-20190271923-A1 | OVERCOAT FOR A PHOTOCONDUCTOR WITH TETRAFUNCTIONAL RADICAL POLYMERIZABLE CHARGE TRANSPORT MOLECULE HAVING HYDROGEN | LEXMARK INTERNATIONAL, INC. | 2019-09-05 | — | — | US | disclosed |
| US-20060051689-A1 | Image forming apparatus and process cartridge | RICOH COMPANY, LTD. (JP) | 2006-03-09 | — | — | US | disclosed |
| US-20060014096-A1 | Image forming method, image forming apparatus and process cartridge therefor | RICOH COMPANY, LTD. (JP) | 2006-01-19 | — | — | US | disclosed |
| US-20050266325-A1 | Outer layer is the crosslinked product of a urethane oligomer having radical polymerizing functional group (e.g., from di(meth)acrylated 1,2,9,10-tetrahydroxy-4,7-dioxadecane), a crosslinking agent, and a reactive charge transport agent, especially acrylated di- or triarylamine; performance & reliability | RICOH COMPANY, LTD. (JP) | 2005-12-01 | — | — | US | disclosed |
| US-20050266328-A1 | Electrophotographic photoreceptor, and image forming method, apparatus and process cartridge therefor using the photoreceptor | RICOH COMPANY LIMITED (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-1600822-A2 | Electrophotographic photoreceptor and image forming method, apparatus and process cartridge therefor using the photoreceptor | Ricoh Company, Ltd. (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-20050141919-A1 | Image forming apparatus and image forming method | RICOH COMPANY, LTD. (JP) | 2005-06-30 | — | — | US | disclosed |
| US-6855746-B2 | Process for the production of molded particles for enzyme- or microbial cell-immobilization | KANSAI PAINT CO., LTD. (JP) | 2005-02-15 | — | — | US | disclosed |
| US-6706778-B2 | AQUEOUS LIQUID CONTAINING POLYURETHANE IS SUBJECTED TO GELATION, THEN SUBJECTED TO PHOTOPOLYMERIZATION AND/OR THERMOPOLYMERIZATION TO TO CAUSE CROSSLINKING REACTION OF ETHYLENICALLY UNSATURATED GROUP IN PARTICULATE GEL | KANSAI PAINT CO., LTD. (JP) | 2004-03-16 | — | — | US | disclosed |
| US-20030100636-A1 | Process for the production of molded particles for enzyme- or microbial cell-immobilization | KANSAI PAINT CO., LTD. (JP) | 2003-05-29 | — | — | US | disclosed |
| US-20020143104-A1 | Process for the production of molded particles for microbial cell-immobilization | KANSAI PAINT CO., LTD. (JP) | 2002-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190271923-A1 | OVERCOAT FOR A PHOTOCONDUCTOR WITH TETRAFUNCTIONAL RADICAL POLYMERIZABLE CHARGE TRANSPORT MOLECULE HAVING HYDROGEN | SLC43A1, DRD4, SLC7A5 | BRD4 2145/4885SLC6A2 492/4885SLC6A4 13/4885 |
| US-10761443-B2 | Charge transport molecule having hydrogen for an overcoat of a photoconductor | SLC43A1, SLC46A1, SLC3A2 | BRD4 1770/4885SLC6A2 154/4885SLC6A4 23/4885 |
| US-10732528-B2 | Overcoat for a photoconductor with tetrafunctional radical polymerizable charge transport molecule having hydrogen | SLC43A1, DRD4, SLC7A5 | BRD4 2145/4885SLC6A2 492/4885SLC6A4 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.